Improving survival prediction for melanoma.

DNA Methylation / genetics Humans Immunotherapy Melanoma / genetics Prognosis Risk Factors Survival Analysis Survival Rate
DNA methylation cancer biology cutaneous melanoma human immune-checkpoint blockade prognostic biomarker risk stratification

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
06 06 2019
Historique:
received: 04 06 2019
accepted: 04 06 2019
entrez: 7 6 2019
pubmed: 7 6 2019
medline: 26 2 2020
Statut: epublish

Résumé

The survival of patients with cutaneous melanoma can be accurately predicted using just four DNA methylation marks.

Identifiants

DOI: 10.7554/eLife.48145 PMID: 31169498 PMC: PMC6553942
pubmed: 31169498
doi: 10.7554/eLife.48145
pii: 48145
pmc: PMC6553942
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2019, Artomov.

Déclaration de conflit d'intérêts

MA No competing interests declared

Références

Cancer Control. 2005 Oct;12(4):223-9
pubmed: 16258493
Clin Chim Acta. 2013 Oct 21;425:169-75
pubmed: 23911908
Nature. 2010 Apr 15;464(7291):993-8
pubmed: 20393554
N Engl J Med. 2006 Jul 6;355(1):51-65
pubmed: 16822996
J Clin Invest. 2017 Aug 1;127(8):3090-3102
pubmed: 28714863
Nat Genet. 2015 Sep;47(9):987-995
pubmed: 26237428
Mol Cancer Ther. 2017 Nov;16(11):2598-2608
pubmed: 28835386
Transl Oncol. 2019 Feb;12(2):350-360
pubmed: 30502589

Auteurs

Mykyta Artomov (M)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, United States.
Broad Institute, Cambridge, United States.
ORCID: 0000-0001-5282-8764

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Méthylation de l'ADN › Improving survival prediction for melanoma.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Improving survival prediction for melanoma.
questionsmedicales.fr › Thérapeutique › Biothérapie › Immunothérapie › Improving survival prediction for melanoma.
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › Improving survival prediction for melanoma.
questionsmedicales.fr › Diagnostic › Pronostic › Improving survival prediction for melanoma.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Improving survival prediction for melanoma.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Analyse de survie › Improving survival prediction for melanoma.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Mortalité › Taux de survie › Improving survival prediction for melanoma.